Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe website footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new history entry was added for 2026-09-15 including a Study Status update and Revision: v3.7.0, while the previous Revision: v3.6.6 was removed. This reflects maintenance/version tracking rather than substantive changes to the study information.SummaryDifference0.0%

- Check41 days agoChange DetectedA new history entry dated 2026-08-28 adds updated Study Status and Contacts/Locations (Revision: v3.6.6, ID 1019), following the removal of the previous 2026-08-04 revision (v3.6.5).SummaryDifference0.0%

- Check69 days agoChange DetectedOn 2026-08-04, a new revision (v3.6.5) was added, introducing the Contacts/Locations section and updating the Study Status on the page. This change affects how the study's contact information and current status are displayed to users.SummaryDifference0.0%

- Check77 days agoChange DetectedDifference0.0%

- Check84 days agoChange DetectedThe Record History page now displays Revision: v3.6.4, replacing the previous v3.6.3; this indicates a small system update to the interface.SummaryDifference0.0%

Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.